Literature DB >> 6722954

Isolation and antitumor activity of cyclic hexapeptides isolated from Rubiae radix.

H Itokawa, K Takeya, N Mori, T Hamanaka, T Sonobe, K Mihara.   

Abstract

Mesh:

Substances:

Year:  1984        PMID: 6722954     DOI: 10.1248/cpb.32.284

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  6 in total

1.  Cyclopeptide RA-V inhibits angiogenesis by down-regulating ERK1/2 phosphorylation in HUVEC and HMEC-1 endothelial cells.

Authors:  Grace G L Yue; Jun-Ting Fan; Julia K M Lee; Guang-Zhi Zeng; Tina W F Ho; Kwok-Pui Fung; Ping-Chung Leung; Ning-Hua Tan; Clara B S Lau
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

2.  Production of monoclonal antibodies against antitumor cyclohexapeptide RA-VII from Rubia cordifolia and their characterization.

Authors:  Tomoyo Hasuda; Yukio Hitotsuyanagi; Koichi Takeya
Journal:  J Nat Med       Date:  2011-02-08       Impact factor: 2.343

3.  Activity of RA-700, a cyclic hexapeptide from Rubiae Radix, in the human tumor clonogenic assay.

Authors:  K Inoue; T Mukaiyama; T Kobayashi; M Ogawa
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

4.  Crosstalk of Cancer Signaling Pathways by Cyclic Hexapeptides and Anthraquinones from Rubia cordifolia.

Authors:  Premalatha Balachandran; Mohamed Ali Ibrahim; Jin Zhang; Mei Wang; David S Pasco; Ilias Muhammad
Journal:  Molecules       Date:  2021-01-31       Impact factor: 4.411

5.  Structural and bioactive studies of terpenes and cyclopeptides from the Genus Rubia.

Authors:  Kuo Xu; Penglong Wang; Bin Yuan; Yatao Cheng; Qiang Li; Haimin Lei
Journal:  Chem Cent J       Date:  2013-05-04       Impact factor: 4.215

6.  Leukocytosis in mice following therapy with a novel antitumor agent, RA-700.

Authors:  T Kato; Y Suzumura; F Z Liu; H Tateno; T Ogiu; K Ota
Journal:  Jpn J Cancer Res       Date:  1989-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.